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Transcriptomics can be combined with TRA and TRB clonotype analysis at the single
cell level. The aim of this study was to validate this approach on the ICELL8 Single-Cell
system and to evaluate its usefulness to analyse clinical paucicellular samples. For this
purpose, we carefully selected T cell lines with defined TRA/TRB clonotypes as well
as clinical samples enriched for CD3+ T cells that possess a complex TCR repertoire.
Low cell numbers of the different samples were dispensed in a chip on the ICELL8
Single-Cell System. Two sequencing libraries were generated from each single cell cDNA
preparation, one for the TRA/TRB repertoire and one for the 5′ ends of transcripts,
and subsequently sequenced. Transcriptome analysis revealed that the cell lines on
average express 2,268 unique genes/cell and T cells of clinical samples 770 unique
genes/cell. The expected combined TRA/TRB clonotype was determined for on average
71% of the cells of the cell lines. In the clinical samples the TRA/TRB repertoire was
more complex than those of the cell lines. Furthermore, the TRB clonotype distribution
of the clinical samples was positively correlated to frequencies of TCRVβ families in
CD3+ T cells obtained by a flow cytometry-based approach (Spearman’s Rho correlation
coefficient 0.81, P= 6.49 ∗ 10−7). Combined analyses showed that transcriptome-based
cell type-specific clusters in clinical samples corresponded to clinical features such as
CMV status. In conclusion, we showed that the ICELL8 Single-Cell System enabled
combined interrogation of both TRA/TRB repertoire and transcriptome of paucicellular
clinical samples. This opens the way to study the response of single T cells within
heterogeneous samples for both their transcriptome and TRA/TRB clonotypes in disease
or upon treatment.
Keywords: single cell transcriptomics, single T cell receptor repertoire analysis, cDNA, combined transcriptome
and T cell receptor repertoire assay, low cell number
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INTRODUCTION
The human body contains a sophisticated immune system
that distinguishes self from non-self-antigens. This requires an
adaptive system that is able to cope with a great range of antigens.
T cells recognize antigens by their unique T cell receptor (TCR),
either of the TCRαβ or TCRγδ type. Approximately 95% of
T cells express a TCRαβ receptor, consisting of a TCRα and
a TCRβ chain. These TCR chains are highly diverse in their
variable domains. In each single cell a unique TCR encoding gene
is formed through a complex recombination process involving
either V and J genes (TCRα or TRA locus) or V, D, and J
genes (TCRβ or TRB locus) (1). This V(D)J recombination
process generates a huge TR repertoire diversity, especially in
the V(D)J junction or complementarity determining region 3
(CDR3), which allows recognition of a broad range of antigens.
Estimates of the number of possible different TCRαβ receptors
amount to 1012 (2, 3). TCRαβ+ cells, which are either CD4+
(T helper) or CD8+ (T cytotoxic), comprise of different subsets
reflecting different maturation stages and functions. Antigen-
inexperienced or naïve T cells have a broad, unselected TCR
repertoire (4) compared to antigen-experienced or memory T
cells that contain TCR repertoires mostly consisting of particular
antigen-selected specificities.
Assays to determine TCR repertoire diversity so far mainly
focused on TCRβ chain profiling, varying fromDNA- (5) or RNA
sequencing-based (6) TRB bulk assays to flow cytometry-based
single cell TCRVβ approaches (7). One major drawback of the
bulk sequencing approaches is the large number of cells required.
Flow cytometry-based assays for analyzing TCRVβ repertoire
diversity at the single cell level are limited to 24 different TCRVβ
families that collectively cover only 70% of the normal human
TCRVβ repertoire. In addition, no information on TCRα profiles
and thus the actual composition of the total TCRαβ receptor
within a sample can be obtained using either one of these
approaches. Furthermore, it remains difficult to examine changes
in TCRαβ repertoire diversity within a heterogeneous pool of
T cells, or low-abundant population like antigen-specific T cells
without purifying them first or acquiring large numbers of cells.
Over the past years, single cell transcriptomics has become
a popular approach and allows to detect the heterogeneity in
gene expression among individual cells and the discovery of small
subpopulations (8). Recently, single cell transcriptomics has been
combined with TR transcript sequencing. This combination
provides gene expression and TCR repertoire information on
a single cell resolution. Several platforms exist for single
cell combined TCR repertoire and transcriptomics analysis,
including 10xGenomics and more recently the ICELL8 Single-
Cell System (9, 10). Single cell transcriptomics usually requires 5–
10K cells (11–13), but little is known about the possibilities using
these single cell-based molecular tools for questioning clinically
relevant paucicellular samples (9, 10).
The aim of this study was to evaluate combined single cell
transcriptome and TRA/TRB repertoire analysis with respect
to clinically relevant samples with low cell numbers on the
ICELL8 Single-Cell System. To this end we validated several
aspects of the combined transcriptome and TR repertoire assay,
using T cell lines with defined TRA/TRB clonotypes. We also
employed clinical samples of end-stage renal disease patients
prior to kidney transplantation, and their donors, which had
previously been characterized in detail for the TRB repertoire
using different approaches.
RESULTS
Characterization of Samples and
Generation of Single Cell Transcriptome
and TR Repertoire Data
With the aim to evaluate the combined single cell transcriptome
and TRA/TRB repertoire analysis in clinically relevant
paucicellular samples, we implemented and applied a combined
humanTCR profiling and differential expressionworkflow on the
ICELL8 Single-Cell System (Figure 1A). This high-throughput
method employs a 5′RACE-like approach to determine both
transcriptomic profiles and complete V(D)J variable regions of
TR transcripts from individual cells (Figure 1B). Two cell lines,
extensively characterized at the (c)DNA level with respect to
TRA and TRB clonotypes, were used to validate the single cell
approach with respect to TR profiling (Table 1). In addition,
three clinical samples were chosen to evaluate the applicability
of the combined assay for paucicellular samples (Table 1). The
latter were characterized for their TRB repertoire diversity,
using a multiplex DNA-based approach (15) as well as a flow
cytometry-based approach with a kit containing antibodies
directed against 24 different TCRVβ families (16).
Peripheral blood mononuclear cells (PBMCs) from clinical
samples were enriched for T cells in an untouched manner
using Fluorescence Activated Cell Sorting (FACS). Cell
viability and CD3+ T cell percentage were determined for
the enriched fraction. Cell viability varied from 50 to 96%
and samples contained >90% CD3+ T cells. To mimick
paucicellular clinical samples, ∼100–200 cells of these enriched
fractions were processed on two independent chips to allow
intra- and inter-chip comparisons. Transcriptome and TR
sequencing results are summarized in Supplementary Table 1,
Supplementary Figure 1. Overall, 43.4% (chip A) and 73.4%
(chip B) of the cells dispensed yielded both transcriptome
as well as TRA/TRB profile data. Notably, sample 3 had a
lower success rate, which correlated with the lower viability
of the cells in this particular sample (Supplementary Table 1),
thereby underlining the importance of high cell viability for the
combined transcriptome and TRA/TRB assay.
Transcriptome Profiling
After filtering dead and doublet cells, 5′-specific transcriptome
data were obtained from 55.7% (chip A) and 88.4%
(chip B) of the cells dispensed (Supplementary Table 1,
Supplementary Figure 1). Even though on average 62% of the
dispensed cells of the clinical samples yielded transcriptome
results vs. 93% of the cell lines (P= 0.01), the average percentage
of mapped reads was not different between cell lines and
clinical samples (89.8% of 31K reads/cell vs. 90.1% of 38K
reads/cell, respectively). Furthermore, a clear correlation
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FIGURE 1 | Workflow for the combined single cell transcriptome and TRA/TRB TCR repertoire assay on the ICELL8 Single-Cell System. (A) Single cells were stained
and dispensed in an ICELL8 chip with 5184 nanowells by the ICELL8 dispenser. Wells with a single viable cell were selected using fluorescent microscopy. On chip
cDNA was synthesized for the selected wells. The synthesized cDNA is collected by centrifugation and split in two aliquots. One aliquot was used to prepare a 5′ end
transcriptome library, while the other aliquot was used to prepare libraries for TRA and TRB transcripts. The 5′ transcriptome library were sequenced single read 50 bp
on an Illumina HiSeq2500 sequencer, whereas the TRA/TRB libraries were sequenced paired end 300 bp on an Illumina MiSeq system. Subsequent bioinformatic
analysis yielded a correlated transcriptome profile and the TRA/TRB clonotypes for each single cell. (B) On chip messenger (m)RNA was isolated using an oligo(dT)
primer. Copy DNA (cDNA) was synthesized for each single cell using a template switching oligo containing a well-specific barcode. cDNA of all wells was pooled by
centrifugation and off-chip two sample preparations were performed, one for the TRA/TRB transcriptome and one for the 5′ ends of the transcripts. The TRA/TRB
sequencing library was constructed by a first PCR making use of the fixed sequence in the switch oligo as well as constant region of the TRA/TRB locus and followed
by a nested PCR. The 5′ end transcriptome library was prepared by cutting the 3′ end of by the nextera transposase and amplified by PCR making use of the fixed
sequence of the switch oligo and tagged sequence by the transposase.
was observed between the number of detected genes and
the number of reads (Supplementary Figure 2). On average
2,268 expressed genes per cell were detected for the cell lines,
whereas in the clinical samples on average 770 expressed
genes/cell could be identified. This difference is mostly likely
explained by the cell lines being transcriptionally more active
as they were cultured prior to use, whereas the clinical samples
were processed immediately upon thawing. Notably, samples
with lower cell viability expressed a lower number of genes,
again stressing the importance of high cell viability of the
starting material for combined single cell transcriptome and
TRA/TRB analysis.
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TABLE 1 | Characteristics of samples used for single-cell transcriptome analysis and TR.
Sample name Clinical characteristic Sample type Chip TRA clonotype(s) TRB clonotype(s) References
MOLT-17 T cell line
(T-ALL type)
B TRAV3-TRAJ5
TRAV12-1-TRAJ9*
TRBV20-1-TRBJ2-3
TRBV27-TRBJ1-1
(14)
HuT78 T cell line
(CTCL type)
B TRAV8-6-TRAJ37
TRAV20-TRAJ24
TRBV13-TRBJ1-2 (14)
Sample 1 CMV-seronegative CD3+ enriched
PBMC fraction
A,B N.D. skewed (15, 16)
Sample 2 CMV-seropositive CD3+ enriched
PBMC fraction
A,B N.D. broad (15, 16)
Sample 3 CMV-seropositive CD3+ enriched
PBMC fraction
A N.D. broad (15, 16)
CTCL, cutaneous T-cell lymphoma; CMV, cytomegalovirus; PBMC, peripheral blood mononuclear cells; TR, T-cell receptor repertoire; T-ALL, T-cell acute lymphoblastic leukemia; N.D.,
not determined.
*This TRA rearrangement has been documented in this cell line, but could not be traced back by single cell NGS or Sanger sequencing in the current DNA batch used.
Reproducibility of Transcriptome Profiles
To evaluate the reproducibility of the single cell transcriptome
data, cells were visualized via t-distributed stochastic neighbor
embedding (t-SNE) (17) -based on the expression of the top
2,000 most variable genes. Separate clusters were detected for
the two cell lines, one cluster for the clinical samples and one
for the assay controls (Figure 2A). We next examined intra-
chip reproducibility by comparing replicate samples (sample 1
r1 and 1 r2; sample 2 r1 and 2 r2; sample 3 r1 and 3 r2) that
were dispensed and processed independently on the same chip
(Figure 2B), whereas inter-chip reproducibility was examined by
processing the same samples on two chips (i.e., sample 1 r1/1r2
and 2 r1/2r2 on chip A vs. 1r3 and 2 r3 on chip B, respectively)
(Figure 2C). As replicate samples were all present in the same
t-SNE cluster and no bias was detected in the locations of the
replicate samples within the cluster, this indicated good intra-
and inter-chip reproducibility.
Cell Type Specificity Detection
As the clinical samples were enriched for T cells by depletion
using a set of antibodies for non-T cell types (so-called
“untouched” enrichment, see methods), we wanted to confirm
that the cells are showing a typical T cell expression profile and
checked for the presence of T cell (Figures 2D–H) and non-T
cell markers (Figure 2I), respectively. Clear expression of CD3D
(Figure 2D) and CD3G (Figure 2E) transcripts was detected in
both clinical and cell line samples. T-cell lineage markers showed
a differential expression profile for the clinical samples, indicating
that these samples contained both CD8A/CD8B- (Figures 2F,G)
as well as CD4–expressing T cells (Figure 2H); also the HuT78,
but not the MOLT-17, cell line show CD4 gene expression.
Expression of the non-T cell CD19 transcript (Figure 2I) was
virtually absent in the clinical samples and the cell lines, which
is in line with prior enrichment for T cells and their T cell clonal
character, respectively.
Single Cell TR Profiling
Next, TR repertoire analysis was performed on the samples from
chip A and B. The extensive PCR amplification required for the
TR profiling gave rise to spurious clusters of clonotypes after
sequencing. For this reason clonotypes were removed when (1)
a clonotype was based on fewer than 25 reads; (2) <80% of
the underlying alignments yielded the same protein sequence;
(3) the clonotype comprised of <0% of the total alignments
for that cell and/or 4) more than two clonotypes below the
top 2 clonotypes per cell were detected. In the complexity
analyses only the top V(D)J transcript was considered, even
though two different TRA and two different TRB transcripts can
theoretically be present per cell. Approximately, 49.9 and 75.7%
of the cells dispensed in chip A and B, respectively, yielded a
TCR profile (Supplementary Table 1, Supplementary Figure 1).
A lower proportion of cells dispensed for the clinical samples
tended to yield TRA/TRB clonotype results, as compared with
the cell lines (averages of 56.1 vs. 77.1%, respectively; P = 0.07),
indicating that TRA/TRB transcripts levels in the more quiescent
cells of the clinical samples are relatively low. No difference
was detected in the range of reads supporting either a TRA or
TRB clonotype, indicating a roughly similar efficiency for TRA
and TRB detection (Figure 3). In contrast to the transcriptome
profiles, the cell lines did show differences in the number of
TRA or TRB clusters, as compared with the clinical samples.
Notably, actual TRA and TRB transcript levels differed between
the cell lines; whereas HuT78 expressed higher TRB transcript
levels, MOLT-17 cells more strongly expressed TRA transcripts
(Figure 3).
Validation of TRA/TRB Clonotypes in Cell
Lines
To validate the single cell approach for TR clonotype detection,
the TR clonotypes of each individual single cell of the two T cell
lines were determined based on the expressed TRA and TRB
transcripts. For the MOLT-17 and HuT78 cell lines, predominant
TR transcripts were apparent and expressed by almost every
cell (Figure 4A). For HuT78, TRBV13∗01-TRBD1∗01-TRBJ1-
2∗01 transcripts were found either alone or in combination
with TRAV20∗01-TRAJ24∗02 and TRAV8-6∗01-TRAJ37∗02
transcripts. In the MOLT-17 cell line, TRAV3∗01-TRAJ5∗01
clonotype was identified alone and in combination with
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FIGURE 2 | Two-dimensional t-SNE visualization based on cellular transcriptome profiles. Cells were projected on a two-dimensional plane based on their gene
expression signals using the t-SNE method. (A,B) The cells are colored according to their respective samples and their replicates. (A) The cells of the 3 patient
samples (blue, red, brown) are mainly placed together in the lower left section of the plot, the MOLT-17 cells (magenta) are placed in the top center section and the
HuT78 cells (gold) are located in the right section of the plot. (B) Intra-chip reproducibility as shown by indicated section of the t-SNE projection including only cells
from chip A. The replicates on chip A for the 3 patient samples show substantial overlap even though some sample specific preferences seem apparent. (C) Inter-chip
reproducibility as shown by the overlap between the cells for chip A (blue) and chip B (green) in the indicated section of (A). (D–J) The scaled gene expression (J) of
the CD3 (D,E), CD8 (F,G), CD4 (H), T-cell and CD19 (I) markers.
TRBV20-01∗01-TRBD2∗01-TRBJ2-3∗01 and TRBV27-01∗01-
TRBD1∗01-TRBJ1-1∗01 clonotypes. All identified clonotypes
matched the expected TRA/TRB clonotypes obtained from
Sanger and NGS data (14) (unpublished results) for each cell
line. On average 63 and 80% of the dispensed HuT78 andMOLT-
17 cells expressed the correct clonotypes, respectively (Table 2).
The single cell TR repertoire assay enabled the detection of two
novel, minor clonotypes: TRBV27∗01/TRBD1∗01/TRBJ1-1∗01
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FIGURE 3 | TRA/TRB clusters per single cell for different samples. The number reads for TRA (upper panel) and TRB (lower panel) clonotypes (depicted on the Y-axis)
for each single cell plotted per sample for chip A and B (depicted on the X-axis).
FIGURE 4 | TRA and TRB clonotypes for cell lines and clinical samples. (A) V(D)J combinations for HuT78 and MOLT-17 cell lines and the mixture of the two cell lines.
Size of the circle shows relative amount. Number inside circle shows number of single cells with specific clonotype. (B) Proportion of cells (Y-axis, %) is plotted against
the V, D, J genes (X-axis) arranged as present in the human genome for TRA (top row) and TRB (bottom row). Colored lines differentiate unique V(D)J combinations,
whereas the width of the line indicates the number of single cells with an identical V(D)J combination.
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and TRAV20∗01//TRAJ24∗02 clonotypes were detected in the
MOLT-17and HuT78 cell lines, respectively (Figure 4A). Finally,
one TRA clonotype (TRAV12.1-TRAJ9) that was previously
identified in the MOLT-17 cell line, could not be traced in our
single cell TR repertoire assay (Table 2). However, more detailed
re-analysis using benchmark methods (Sanger, NGS) revealed
that this clonotype was actually missing from the currently used
cell line batch.
Complexity of TRA/TRB Clonotypes in
Clinical Samples
Next, we evaluated the TRA/TRB repertoire of T cells in the
clinical samples. Contrary to the cell lines CD3+ T cells from
the clinical samples showed equal TRA and TRB transcript levels
(Figure 3). All V(D)J combinations of the clinical samples were
analyzed and are shown in Figure 4B. Even though the exact
V(D)J profiles differed between sample 1 and sample 2, their
TR clonotype complexity was rather similar. To investigate if
the single cell method would be capable of detecting skewed
TR repertoires in clinical samples, the number of unique
V(D)J combinations was determined in sample 1 (skewed TRB
repertoire) and compared to sample 2 (broad TRB repertoire)
(Supplementary Figure 3). This revealed that the majority of the
cells of both clinical samples expressed unique V(D)J clonotypes,
both for TRA and TRB. With only up to 9 identical TR
clonotypes being detected in about 200 cells analyzed per cell
sample, the repertoire of both clinical samples appeared diverse,
probably illustrating that this number of analyzed cells in the
current setting is not sufficient to distinguish skewed from broad
TR repertoires.
Association of Single Cell TRB Clonotype
With Single Cell TCRVβ Staining Detected
by Flow Cytometry
To further validate the accuracy of single cell TRB clonotype
detection in clinical samples, we took advantage of detailed
flow cytometry-based TCRVβ repertoire data for CD3+ T cells
of the clinical samples (16). In the flow cytometry approach
three different TCRVβ families were measured concurrently in
8 different tubes, with 0.5–1 million of CD3+ T cells per tube.
The resulting profile of the 24 different TCRVβ families was
compared to the TRB profile obtained by the combined single cell
mRNA-based assay (Figure 5). The Spearman’s Rho correlation
coefficients between the datasets amounted to 0.82 for sample 1
(P = 6.49∗10−7) and 0.81 for sample 2 (P = 1.13∗10−6). For this
comparison, sample 3 was not taken into consideration, as the
viability was only 50%, resulting in an inadequate representation
of TRB clonotype transcripts. Altogether, the transcript-based
single cell assay showed a fairly good correlation with the protein-
based single cell flow cytometry assay for TRB clonotypes.
Cell Types Within the Clinical Samples
Finally, we zoomed in on the transcriptomes of the clinical
samples and valuated whether expression differences might
correlate with the skewed/clonal nature of the TRB repertoire
(15) or with clinical features. In the initial t-SNE projection, the
clinical samples were projected as a complex shape indicating
the presence of different T cell types in these samples (Figure 2).
We therefore clustered the cells of the different clinical samples
based on their expression patterns, which resulted in three
separate clusters (Figure 6A). These three clusters roughly
corresponded to the presence or absence of the classical T cell
markers CD4 and CD8. In cluster 1, CD4 was predominantly
expressed and cluster 2 contained many cells with high CD8
expression. Cluster 0 represented single cells in which low
levels of CD8 and CD4 transcripts were present (see also
Figure 2). Furthermore in cluster 1, genes important for homing
to secondary lymphoid organs (SELL) and T cell maintenance
(IL2RG) were expressed (Figure 6B). Cluster 2 represented genes
associated with cytotoxic effector function as would be expected
for the predominant CD8-expressing T cell population within
this cluster. In cluster 0, genes were primarily downregulated
compared to the cells in clusters 1 and 2.
Over- and under-representation of cell types in the three
clinical samples was subsequently determined using a Fisher
exact test (Figure 6C). In general, sample 1 had a distinct
transcriptome profile compared to sample 2 and 3, which were
more alike (Figure 6C). Interestingly, sample 2 and 3 appeared
to have more cells belonging to cluster 2 when compared
TABLE 2 | Results TRA/TRB clonotypes for the two T cell lines.
Cell line DNA level DNA OK? Single cell Sum score Cells Total cells
MOLT-17 TRAV3-TRAJ5 Yes TRAV3*01//TRAJ5*01 164,413 72 72
MOLT-17 TRAV12-1-TRAJ9 Yes ND NA NA 72
MOLT-17 TRBV20-1-TRBJ2-3 Yes TRBV20-1*01,TRBV20-1*02/TRBD2*01/TRBJ2-3*01 8,243 52 72
MOLT-17 TRBV27-TRBJ1-1 NA TRBV27*01/TRBD1*01/TRBJ1-1*01 6,948 47 72
HuT78 TRAV8-6-TRAJ37 Yes TRAV8-6*02//TRAJ37*02 9,982 39 106
HuT78 TRAV20-TRAJ24 NA TRAV20*01//TRAJ24*02 13,618 55 106
HuT78 TRBV13-TRBJ1-2 Yes TRBV13*01/TRBD1*01/TRBJ1-2*01 226,032 106 106
HuT78 TRBD2-TRBJ2-3 Yes ND NA NA 106
HuT78 TRBD1-TRBJ1-2 No ND NA NA 106
Pos Ctrl (RNA) NA NA TRBV12-3*01//TRBJ1-2*01 46,029 9 9
N.A., not analyzed; N.D., not detected.
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FIGURE 5 | Correlation of single cell TRB clonotypes with BetaMark flow-based single cell TCRVβ test. Shown are the percentages of 24 TCRVβ families for sample 1
and sample 2 as obtained using BetaMark kit (depicted in blue) together with the TCRVβ reference values as determined using 10 healthy donors (depicted with black
line) vs. single cell TRB clonotypes (depicted in red).
to sample 1. Of note, sample 2 and 3 were both derived
from cytomegalovirus (CMV)-seropositive individuals, whereas
sample 1 was from a CMV-seronegative individual, which might
well explain differences in the number of CD8+ T cells. Previous
research revealed skewing to primarily occur within CD8+
memory T cells (15, 16), but since only 19 cells within the skewed
sample 1 expressed CD8 we could not confirm their character
based on transcriptome profile.
DISCUSSION
In this study, we evaluated the combined assay for transcriptome
and TRA/TRB repertoire on the ICELL8 Single-Cell System in
view of applications to interrogate heterogeneous, paucicellular
clinical samples. Our results show that it is possible to
accurately study ∼100–200 cells/sample with respect to parallel
transcriptome and TRA/TRB clonotype repertoire analysis.
Comparison of T cell lines to paucicellular clinical samples
enriched for T cells revealed distinct transcriptome profiles and
allowed to discriminate T cells with a more or less clonal nature
(cell lines) from those possessing a complex TRA/TRB clonotype
repertoire (clinical samples).
One of the first single cell approaches to link TCR-sequencing
data to T cell functional phenotype was based on RT PCR
and made use of primers for TCR and a limited number
of T-cell related functional genes (18). Since then, single cell
RNA sequencing platforms have been developed to unravel
the full transcriptome in an unbiased manner (9). These allow
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FIGURE 6 | Single-cell transcriptomics reveals three cell type-specific clusters for the clinical samples. (A) t-SNE visualization showing the clusters. Cluster 0
represents cells mainly negative for CD4 and CD8 (depicted in red), cluster 1 predominantly consists of CD4+ T cells (depicted in green) and cluster 2 that of CD8+ T
cells (depicted in blue). (B) Differential expression analysis of the cells in the cluster vs. the cells outside of the cluster. The fold changes (X-axis) and adjusted P-values
(y-axis) are depicted for the genes and top 5 marker genes per cluster are shown. (C) Over-/underrepresentation of each of the clinical samples is depicted for the
three clusters.
for characterization of heterogenous and rare cell populations
(10) unlike the bulk-based approaches (Table 3). Bulk NGS
predominantly focuses on TRB clonotypes as analysis of TRA
clonotypes is more challenging. Protein-based analysis of TCR
repertoire at a single cell level using a flow cytometry-based
platform also mainly focuses on the TCRVβ repertoire. The
limited availability of different TCRVβ antibodies does not allow
for simultaneous evaluation of TCRVβ and TCRVα families.
Single cell RNA sequencing does allow for combined analysis of
the TRA/TRB repertoire. The TRA/TRB repertoire can either be
deduced from transcriptome data using computational methods
(19) or analyzed following a TCR-specific PCR from cDNA
generated from a single cell like employed by the ICELL8
Single-Cell System. Each platform has its own features making
it a more or less appropriate platform to choose based on
the population of interest, i.e., being a more homogeneous
or heterogeneous pool of cells, starting amount of cells, etc.
(9). Both 10xGenomics (20), a droplet-based platform, as
well as the ICELL8 Single-Cell System, a chip-based platform,
have developed a workflow for combined TCR repertoire and
transcriptome analysis at the single cell level and both methods
are constantly improving with respect to handling low amounts
of starting material.
Validation of the TRA/TRB clonotype composition of single
cells dispensed from cell lines against bulk sequencing using
Sanger and/or NGS confirmed clonotypes, indicated that low
numbers of cells of a more or less homogeneous nature can
be used for interrogating the TRA/TRB clonotype repertoire.
Moreover, single cell analysis of TRA/TRB clonotypes showed
increased resolution and revealed minor clonotypes that were
missed using Sanger sequencing, albeit that these could also
be found in bulk NGS analysis. Clinical samples were distinct
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TABLE 3 | Comparison of different platforms for studying TCRαβ repertoire diversity at the single cell level.
ICELL8 Single-Cell
System methodology
10x Genomics
methodology
NGS sequencing TCRVβ profiling
Material type RNA-based RNA-based DNA/RNA-based Protein-based
TRA/TRB combination + + ± (TRA is challenging) - (TCRVα Ab panel limited)
Combined sc TRA/TRB and
transcriptome
+ + – n.a.
Single cell approach + + – +
Range of cells/sample 50–1,800* 500–10,000 Range 10,000–100,000 10,000–4,000,000
n.a., not applicable, *due to Poissions distribution of single cells ∼1/3 of the chip can be filled.
from cell lines and revealed increased complexity with respect
to their TRA/TRB repertoire. The fact that a lower frequency
of cells dispensed from clinical samples yielded TRA/TRB
clonotype results when compared to the cell lines, could be
attributed to several factors. First, and perhaps most likely,
TRA/TRB transcript levels might be lower in quiescent cells when
compared with cell lines. Second, enrichment for CD3+ T cells
was not 100%, resulting in the presence of some CD3− cells
amongst those dispensed, which are typically lacking TRA/TRB
clonotypes. Third, ∼0.5–10% of CD3+ T cells in the circulation
are TCRγδ+ T cells (21), which would thus be lacking TRA/TRB
transcripts as well.
We have previously described that at the bulk DNA level,
clinical samples with a polyclonal TRB repertoire could be
distinguished from those possessing a more skewed, oligoclonal
TRB repertoire. In fact, detailed analysis of the TRB repertoire
revealed that memory T cells, in particular CD8+ memory T
cells of elderly patients suffering from end-stage renal disease
have an oligoclonal TRB repertoire (15). In the current single
cell study, we were unable to distinguish between clinical samples
having a broad TRB repertoire and those having a skewed TRB
repertoire at the single cell level. This might be caused by the
fact that the clinical samples used in our current study, although
enriched for T cells, still contained cells of a heterogeneous
nature, i.e., both CD4+ and CD8+ T cells, and both antigen-
inexperienced (naïve) and antigen-experienced (memory) T cells.
All these cells have different phenotypes, functions and TRA/TRB
repertoires. The proportion of memory T cells dispensed for
the clinical samples, used in this study, might have been too
low and still even too diverse with respect to the TRA/TRB
repertoire to identify samples with a skewed repertoire. To be
able to use the single cell TR analysis for specific research
questions on TR repertoire skewing, larger cell numbers may be
required to observe grouping of cells with a similar TR repertoire.
Furthermore, prior purification of populations of interest might
also facilitate addressing these questions.
In this respect one could think of activated or memory T cell
fractions (19, 22). Despite the fact that clinical samples with a
skewed TRA/TRB repertoire could not be distinguished from
those possessing a broader repertoire of TRA/TRB clonotypes
at the single cell level, differences in transcriptome profiles
were observed between quiescent paucicellular clinical samples.
These could be linked to clinical characteristics of the samples.
Clinical sample 1 was distinct from sample 2 and 3, with the
latter two showing more similar transcriptome profiles with
increased transcripts of genes associated with cytotoxic effector
function. This might be caused primarily by the fact that the latter
two represent CMV-seropositive individuals, as different age
categories did not distinguish these two samples from each other.
CMV is known to be a major factor shaping T cell immunity,
such as increasing the proportion of CD4+ T cells with cytotoxic
features, and expanding the CD8+ T cell pool with increased
cytotoxic potential (23–25).
Strikingly, transcripts of TRB clonotypes strongly correlated
to protein levels of the 24 different TCRVβ families,
indicating that TRB (and as a further implication perhaps
also TRA) repertoire analysis at the single cell level is feasible
in paucicellular clinical samples with a good resolution.
Unfortunately we only had few samples for this comparison.
Interestingly, using the flow cytometry-based assay large
numbers of T cells (4–8 million) are acquired (16), compared
with the 100–200 single T cells that were dispensed for TRA/TRB
repertoire analysis in this study. The large cell number together
with the multi-parameter nature of the flow cytometry-based
approach to discriminate naïve T cells from memory T cells
allows to interrogate the TCRVβ repertoire diversity of T
cell subsets. However, the advantage of the current single cell
approach is that a more detailed and complete TRA/TRB
clonotype analysis can be performed compared with antibodies
that just recognize TCRVβ domains and only cover 70% of
all specificities. Furthermore, by looking at transcripts for
specific markers that define naïve vs. memory subsets, single cell
TRA/TRB clonotype evaluation would still be possible in the
context of T cell subsets.
We noticed a higher proportion of cells from the cell lines
with evaluable transcriptome data compared to clinical samples,
which is most probably due to the cell lines being cultured,
whereas the clinical samples were thawed and enriched for T
cells, immediately before analysis. Transcript expression would
be lower in such primary samples, as they are most likely not
transcriptionally active. Nevertheless, transcript levels of genes
specific for the cell types used in our assay, could be detected
and allowed us to confirm their cellular origin. Evaluation of the
transcriptome of antigen-specific T cells at the single cell level
requires stimulation of clinical samples with a particular antigen.
Short-term antigenic stimulation induces mRNA expression and
thus offers the possibility to distinguish activated from non-
activated T cells based on evaluation of specific transcripts
from markers that are upregulated on the T cell membrane
(26, 27). CD154 and/or CD137 are upregulated upon interaction
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of a specific TCR with an HLA-antigen complex on antigen
presenting cells, thereby facilitating a simultaneous interrogation
of the specific TRA/TRB clonotype profile of CD154- and/or
CD137- expressing, activated T cells. Based on our current
results, we would recommend to first enrich for these antigen-
specific/activated T cells using flow cytometry-based cell sorting,
prior to addressing research questions concerning differences
in transcriptome profiles of antigen-specific T cells in time or
between different clinical samples. Selection of antigen-specific
T cells following stimulation using flow-cytometry-based cell
sorting has indeed been applied by Huang et al. (22). These
authors used SELECT-seq, a tool applied to specifically analyse
transcriptome and TCR composition of over 3000 antigen-
specific T cells by first employing a targeted PCR on Smart-Seq2-
derived cDNA libraries from sorted antigen-specific CD137+ or
CD154+ T cells. This allowed for identification of duplicates of
TCR sequences resembling clonally expanded antigen-specific T
cells, whereafter cells are selected for in-depth single cell RNA
sequencing (22). Elthala et al. showed that low cell numbers,
i.e., 21 cells per condition, of antigen-specific T cells could be
used successfully for studying transcriptome as well as TCR
repertoire, taking TCR related reads from transcriptome data
using computational methods (19).
In this study, we initially started with a concentration of
0.75–2 × 106 cells and a sample volume of at least 2mL.
However, only a fraction of the suspension was used to mimick
working with paucicellular samples. For actual paucicellular
clinical or biological samples such starting cell concentrations
and volumes would often be challenging, or virtually impossible.
Optimization of dispension of cells in a chip would thus be
required, which could be achieved by using a different dispension
method. The currently used Takara technology (13) dispenses
according to the limiting dilution method, thus allowing for
∼1/3 (Poisson) of the chip to be filled with single cells, while
the other wells of the 72-by-72 chip contain either no cells or
>1 cell and are therefore not further processed. The CellenOne
dispenser (28), however, allows for a more efficient dispension of
wells, thus increasing opportunities for analyzing lower volumes
of clinical samples. Importantly, dispension of low numbers
of cells of clinical samples in duplicate on one chip or on
two different chips did not affect reproducibility, suggesting
that downstream processing of a sample containing low cell
numbers is not compromised. Further research should therefore
focus on optimizing dispension methods to increase optimal
use of cells in paucicellular clinical samples. Additionally, the
minimal number of T cells required to identify samples/cells with
a skewed/oligoclonal TRA/TRB repertoire should be assessed,
although it should be noted that the latter would also be
dependent on the nature of the samples used.
In conclusion, we showed that the ICELL8 Single-Cell System
enabled combined interrogation of both the TRA/TRB repertoire
and the transcriptome of paucicellular clinical samples. The
single cell TR assay was further validated against the BetaMark
TCRVβ single cell flow assay. This opens the way to study the
response of single T cells within heterogeneous samples for
both their transcriptome and TRA/TRB clonotypes in disease or
upon treatment.
MATERIALS AND METHODS
Cell Samples
In order to validate the ICELL8 Single-Cell System (Takara
Bio, Shiga, Japan) for combined single cell transcriptome and
TR profiling for clinically relevant samples, we used two
different cell lines, with known TRA/TRB clonotypes (14) as
deduced from Sanger as well as NGS analysis data (Table 1).
In addition, we used three different clinical samples, one
of which had a skewed/oligoclonal TRB repertoire (Table 1,
sample 1) and two of which showed a broad/polyclonal TRB
repertoire (Table 1, sample 2 and sample 3), as determined
by DNA-based TRB spectratyping (15). Clinical samples had
been immunophenotyped in depth with respect to the presence
of the different T cell subsets as well as their differentiation
status (29, 30). PBMCs from these samples had been isolated
from heparinized blood using Ficoll-Paque Plus (GE Healthcare,
Uppsala, Sweden) density centrifugation (31), and stored in
liquid nitrogen with a minimum amount of 10 × 106 cells
per vial. In addition to TRB spectratyping on bulk DNA (15),
a detailed characterization of the TCRVβ repertoire for the
different T cell populations had been performed previously
using the TCRVβ antibody kit (IOTest R© Beta Mark, Beckman
Coulter Nederland B.V., Woerden, Netherlands) (16). For
sample 1 (skewed TRB repertoire), two TCRVβ families were
more prevalent compared to reference values, i.e., TCRVβ3
and TCRVβ13.6, corresponding to TRB28 and TRB6-6 in the
IMGT nomenclature, respectively. To validate the combined
single cell transcriptome and TRA/TRB profiling assay for
these clinical samples, 1 vial of ∼10 million PBMCs was
thawed and cell viability was assessed using trypan blue
(Supplementary Table 1). Two out of three samples contained
<20% of dead cells whereas the third one contained 50% of
dead cells. Samples were enriched for T cells, in an untouched
manner, using the PAN T cell isolation kit (Miltenyi Biotec B.V.,
Bergisch Gladbach, Germany) according to the manufacturer’s
instructions. Following this enrichment step, the frequency
of CD3+ T cells amounted to >90%. Sorted cell samples
were resuspended in degassed sterile PBS (without Mg2+ and
Ca2+, Invitrogen; Landsmeer, Netherlands), pH 7.4 at room
temperature at a concentration 2 × 106/mL. To mimick analysis
of samples with low cell numbers, from these cell suspensions
eventually 100–200 cells were dispensed in the chip (see below).
Combined Single Cell Transcriptome and
TRA/TRB Repertoire Analysis
Cell Dispension
Cells were stained with Hoechst and propidium iodide (PI)
using the Ready Probes Cell viability Imaging kit (Thermo Fisher
Scientific, Waltham (MA), USA) according to the manufacturer’s
recommendation. Cells were dispensed into nanowells of a
blanco chip using the ICELL8 Single-Cell System (Takara Bio)
to determine the optimal cell concentration yielding a Poisson
distribution value between 0.8 and 1.2 for optimal single cell
dispension. Based on the obtained Poisson distribution value,
cells were diluted and dispensed in a pre-printed chip with the
ICELL8 Single-Cell System, using a suspension of 20K cells/µl.
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Each pre-printed TCR chip contains 1,728 unique barcodes and
each barcode is pre-printed three times on the chip (Takara
Bio). Positive control nanowells were dispensed with 5 pg
Jurkat RNA and negative control nanowells with 1x PBS. After
dispensing cells, the chip was imaged with a 4x objective for
Hoechst and PI fluorescent signal and analyzed using CellSelect
automated microscopy image analysis software (Takara Bio).
Wells with positive Hoechst signal and negative for PI signal were
selected for further processing, whereasempty wells and wells
with multiple single cells were excluded.
cDNA Synthesis
Fifty nanoliter of SMART RT-PCR reagents (Takara Bio)
were dispensed to all selected wells and full-length cDNA
was amplified in-chip for 24 cycles using SMARTScribe
reverse transcriptase according to manufacturer’s instructions
(Figure 1B). Barcoded amplicons were collected into a tube by
centrifugation and off-chip purified with the NucleoSpin Gel and
PCR Clean-up kit (Machery-Nagel, Düren, Germany) followed
by an AMPure XP beads purification (Beckman Coulter, Brea,
USA). cDNA synthesis, purification and size selection were
checked on a Bioanalyzer using the High sensitivity DNA kit
[Agilent Technologies, Santa Clara (CA), USA]. The resulting
cDNA library was split for either TRA/TRB amplification or
whole transcriptome amplification.
TR Amplification
TRA and TRB transcripts were amplified by PCR for 16 cycles
using primers specific for human TRA and TRB constant
region sequences, respectively, according to the manufacturer’s
instructions (Figure 1B). A semi-nested PCR was performed
for 14 cycles to further amplify transcripts from both TR loci
and to add the Illumina adaptor sequences (Figure 1B). The
resulting TR sequencing libraries were purified and size-selected
for ∼400–900 bp fragments with AMPure XP beads. Sequencing
libraries were quantified by Quant-it assay, diluted, and checked
on a Bioanalyzer using the High sensitivity DNA kit. From the
sequencing libraries, paired-end reads of 300 bp length were
sequenced with an 8 bp index on an Illumina MiSeq sequencer
according to the protocol by Illumina [San Diego (CA), USA].
5′-Specific WTA
For transcriptome analysis, part of the purified cDNA was
tagmented using the Nextera XT DNA library prep (Illumina)
and Illumina adaptor and indices sequences were extended by
a 12 cycle PCR according to the manufacturer’s instructions
(Figure 1B). The resulting whole transcriptome sequencing
libraries were purified and size-selected for ∼400–900 bp
fragments with AMPure XP beads. The sequencing libraries were
quantified with the Quant-it assay and checked on a Bioanalyzer
using the High sensitivity DNA kit. Sequencing libraries were
sequenced according to the Illumina TruSeq Rapid v2 protocol
on Illumina HiSeq2500 sequencer. Single reads were generated
of 50 bp in length with a single 8 bp index sequence.
Transcriptome Analysis
For RNA expression data analysis well-barcodes and Illumina
adapter sequences were removed from the reads using in-house
developed software. The remaining sequences were aligned to
the GRCh38 human reference genome extended with exon-exon
junctions using the HISAT2 aligner (32). Resulting alignments
were annotated with the well-barcodes and converted to BAM
format using SAMtools (33). The alignments were converted
to BED entries and intersected using Ensembl exons (release
96) (34) using BEDtools (35). Per gene quantification was then
performed with further in-house software.
Subsequent analysis was performed using the Seurat single
cell analysis package version v3.1.4 (36) in R (version 3.6.3).
Cells were filtered from the analysis, if a cell had more than 5%
mitochondrial signal, fewer than 500 or more than 5,000 genes,
the latter based on the assumption that too many detected genes
are most likely the result from doublets of cells instead of single
cells (36). The expression signals were scaled and normalized
using the appropriate methods from Seurat and dimensional
reduction was performed using a principal component analysis
based on the 2,000 most highly variable (protein coding) genes.
The first 5 dimensions in the dataset were used for the t-SNE
visualization and cell-type analysis.
In the cell type analysis, cells were first clustered based on
their expression profiles (top 5 dimensions, resolution 0.4). To
gain insights into the cell type represented by the clusters,
differential expression analyses were performed of the clusters
compared the other cells. Using the Fisher exact method,
the over- and under-representation of samples in the clusters
were tested.
TR Analysis
Forward and reverse reads for the TR data were merged
using PEAR (version 0.9.2) (37). The assembled sequences
were then aligned to IMGT-defined TR V, D, and J reference
sequences (38) using the IgBLAST tool (version 1.14) (39). The
resulting alignments were processed further in R (version 3.6.3).
Throughout the analysis, the tidyverse packages for R were
used (40).
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Supplementary Figure 1 | Summary of transcriptome and TR sequencing output
of different chips. Occupancy and success rate of dispensed single cells (left), TR
(middle), and transcriptome profiles (right) visualized as successful wells (black) or
unsuccessful wells (red).
Supplementary Figure 2 | Overall transcript levels of clinical samples and cell
lines. The number of genes (Y-axis) is plotted against the number of reads in
thousands (X-axis) for each individual single cell. Individual samples are indicated
at the top with their sample names.
Supplementary Figure 3 | Unique TRA and TRB combinations. The number of
cells with identical for TRA (top, blue) or TRB (bottom, red) clonotypes for clincal
samples 1 (left) and 2 (right) is plotted against the V(D)J combination ranked for
occurrence.
Supplementary Table 1 | In depth characteristics of the single cell transcriptome
and TCR experiments.
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